Oxurion Expands Clinical Research Capabilities with Strategic Partnership

Oxurion NV, a biopharmaceutical company in Leuven, Belgium, has announced a strategic partnership between its subsidiary Axiodis CRO and KYomed INNOV & CEISO, a French clinical CRO specializing in digital health and medical device research. This collaboration aims to enhance clinical data management and biometrics services.

This partnership addresses increasing industry demands by providing robust biometrics support from study design to statistical analysis. The collaboration allows Axiodis CRO to offer its specialist services, optimizing study design and strengthening data quality.

The partnership is expected to generate EUR 110,000 in annual revenue, with potential growth up to EUR 170,000. It supports Oxurion's strategy of integrating scientific services with technology-enabled operations to meet growing demands in clinical research.